You just read:

Haemonetics Reports 4th Quarter Fiscal 2014 Revenue of $241 Million and Adjusted EPS of $0.46; Full Year Revenue of $939 Million, Up 5% and Adjusted EPS of $2.19, Up 10%

News provided by

Haemonetics Corporation

Apr 28, 2014, 06:00 ET